Hypozincemia in COVID-19 Patients Correlates With Stronger Antibody Response

Hypozincemia in COVID-19 Patients Correlates With Stronger Antibody Response

Zinc ion as an enzyme cofactor exhibits antiviral and anti-inflammatory activity during infection, but circulating zinc ion level during Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection is unclear. This study aimed to evaluate serum zinc ion level in Coronavirus Disease 2019 (C...

Full description

Bibliographic Details
Main Authors:	Wenye Xu, Yingzhi Liu, Xuan Zou, Huanle Luo, Weihua Wu, Junjie Xia, Matthew T. V. Chan, Shisong Fang, Yuelong Shu, William K. K. Wu, Lin Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-01-01
Series:	Frontiers in Immunology
Subjects:	zinc RBD antibody SARS – CoV – 2 COVID - 19
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.785599/full

Similar Items

Clinical and biochemical studies on zinc deficiency (hypozincemia) of goat and sheep
by: Khaleel Zainel Khaleel
Published: (2013-06-01)

SARS-CoV-2 Variants, RBD Mutations, Binding Affinity, and Antibody Escape
by: Lin Yang, et al.
Published: (2021-11-01)

Tag-Free SARS-CoV-2 Receptor Binding Domain (RBD), but Not C-Terminal Tagged SARS-CoV-2 RBD, Induces a Rapid and Potent Neutralizing Antibody Response
by: Ting-Wei Lin, et al.
Published: (2022-10-01)

Retrospective study on the therapeutic efficacy of zinc acetate hydrate administration to patients with hypozincemia-induced dysgeusia
by: Tomoaki Shintani, et al.
Published: (2023-03-01)

Longer Intervals before Vaccination Increase Spike Antibody Titers in Individuals Previously Infected with SARS-CoV-2
by: Xiuqiong Bi, et al.
Published: (2022-04-01)

Analysis of Factors Affecting Neutralizing Antibody Production after COVID-19 Vaccination Using Newly Developed Rapid Point-of-Care Test
by: Hyeon Woo Shim, et al.
Published: (2022-08-01)

Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2
by: Jiajia Xie, et al.
Published: (2021-08-01)

Is Hypozincemia Related to Tinnitus?: A Population Study Using Data From the Korea National Health and Nutrition Examination Survey
by: Hyung Jin Jun, et al.
Published: (2015-12-01)

Effects of Zinc Acetate Hydrate Supplementation on Renal Anemia with Hypozincemia in Hemodialysis Patients
by: Eiichi Sato, et al.
Published: (2022-10-01)

Combining a Fusion Inhibitory Peptide Targeting the MERS-CoV S2 Protein HR1 Domain and a Neutralizing Antibody Specific for the S1 Protein Receptor-Binding Domain (RBD) Showed Potent Synergism against Pseudotyped MERS-CoV with or without Mutations in RBD
by: Cong Wang, et al.
Published: (2019-01-01)

Antibodies and Vaccines Target RBD of SARS-CoV-2
by: Long Min, et al.
Published: (2021-04-01)

Murine Monoclonal Antibodies against the Receptor Binding Domain of SARS-CoV-2 Neutralize Authentic Wild-Type SARS-CoV-2 as Well as B.1.1.7 and B.1.351 Viruses and Protect <italic toggle="yes">In Vivo</italic> in a Mouse Model in a Neutralization-Dependent Manner
by: Fatima Amanat, et al.
Published: (2021-08-01)

Neutralizing antibodies from the rare convalescent donors elicited antibody-dependent enhancement of SARS-CoV-2 variants infection
by: Song Mu, et al.
Published: (2022-10-01)

Evaluation of Antibody Level of COVID-19 Vaccines among the Staff of the Razi Teaching Hospital in Qaemshahr at Least 6 Months after Receiving the Third Dose
by: Farhang Babamahmoodi, et al.
Published: (2023-12-01)

Neutralizing antibodies targeting SARS-CoV-2 spike protein
by: Shi Xiaojie, et al.
Published: (2021-01-01)

Heterologous Booster with BNT162b2 Induced High Specific Antibody Levels in CoronaVac Vaccinees
by: Letícia Carrijo Masson, et al.
Published: (2023-06-01)

Longitudinal Profiling of Antibody Response in Patients With COVID-19 in a Tertiary Care Hospital in Beijing, China
by: Xia Feng, et al.
Published: (2021-03-01)

Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants
by: Chunyan Yi, et al.
Published: (2021-10-01)

High seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers
by: Tesfaye Gelanew, et al.
Published: (2022-03-01)

Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
by: Xiaolong Tian, et al.
Published: (2020-01-01)

IgG Antibodies Develop to Spike but Not to the Nucleocapsid Viral Protein in Many Asymptomatic and Light COVID-19 Cases
by: Maria Tutukina, et al.
Published: (2021-09-01)

Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape
by: Jamille Ramos Oliveira, et al.
Published: (2023-01-01)

Pre-existing humoral immunity to low pathogenic human coronaviruses exhibits limited cross-reactive antibodies response against SARS-CoV-2 in children
by: Nina Li, et al.
Published: (2022-10-01)

Lasting SARS-CoV-2 specific IgG Antibody response in health care workers from Venezuela, 6 months after vaccination with Sputnik V
by: Franklin Claro, et al.
Published: (2022-09-01)

Induction of Potent and Durable Neutralizing Antibodies Against SARS-CoV-2 Using a Receptor Binding Domain-Based Immunogen
by: Vikram Srivastava, et al.
Published: (2021-03-01)

Inducing enhanced neutralizing antibodies against broad SARS-CoV-2 variants through glycan-shielding multiple non-neutralizing epitopes of RBD
by: Qingyun Zhang, et al.
Published: (2023-12-01)

The risk factors of SARS-CoV-2 antibody level differences in healthcare workers post vaccination in Siloam hospitals: A nationwide multicenter study
by: Allen Widysanto, et al.
Published: (2022-12-01)

RBD-Protein/Peptide Vaccine UB-612 Elicits Mucosal and Fc-Mediated Antibody Responses against SARS-CoV-2 in Cynomolgus Macaques
by: Shixia Wang, et al.
Published: (2023-12-01)

Antibodies to NCP, RBD and S2 SARS-CoV-2 in Vaccinated and Unvaccinated Healthcare Workers
by: Agata Błaszczuk, et al.
Published: (2022-07-01)

Prevalence of SARS-CoV-2 antibodies after the Omicron surge, Kingston, Jamaica, 2022
by: Joshua J. Anzinger, et al.
Published: (2022-11-01)

Delivery of mRNA Vaccine against SARS-CoV-2 Using a Polyglucin:Spermidine Conjugate
by: Larisa I. Karpenko, et al.
Published: (2021-01-01)

A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations
by: Federico Bertoglio, et al.
Published: (2021-07-01)

Establishment of Murine Hybridoma Cells Producing Antibodies against Spike Protein of SARS-CoV-2
by: Nadezhda V. Antipova, et al.
Published: (2020-12-01)

Seroprevalence of Anti-S1-RBD Antibodies in Pre-pandemic and Pandemic Subjects From Hail Region, KSA
by: Subuhi Sherwani, et al.
Published: (2022-06-01)

A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2
by: Xiaojian Han, et al.
Published: (2021-03-01)

Antibody Response to SARS-CoV-2 Membrane Protein in Patients of the Acute and Convalescent Phase of COVID-19
by: Philipp Jörrißen, et al.
Published: (2021-08-01)

Comparison between Neutralization Capacity of Antibodies Elicited by COVID-19 Natural Infection and Vaccination in Indonesia: A Prospective Cohort
by: Sitti Nurisyah, et al.
Published: (2023-09-01)

SARS-CoV-2 spike antigen-specific B cell and antibody responses in pre-vaccination period COVID-19 convalescent males and females with or without post-covid condition
by: Marc-André Limoges, et al.
Published: (2023-09-01)

Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class
by: Micah Rapp, et al.
Published: (2021-04-01)

Recombinant COVID-19 vaccine based on recombinant RBD/Nucleoprotein and saponin adjuvant induces long-lasting neutralizing antibodies and cellular immunity
by: Amir Ghaemi, et al.
Published: (2022-09-01)